정기총회 및 학술대회
대한약국학회 주관하는 교육/행사입니다.
대한약국학회 2023년도 정기총회 및 정기학술대회
데이터 기반 지역약국 약료서비스의 현재와 미래
2023년 11월 26일(일) 10:00~17:00 / 한국과학기술회관 12층 아나이스홀
초록/포스터
Byeongjin Kang-퇴행성관절염-전주종로약국
작성일 : 2020-11-27 오후 7:35:51 작성자 : 남윤진 조회수 : 496
A Case Report of Osteorthritis and
comparative analysis with guidelines
Byeongjin Kang, Jongwan Kim / College of Pharmacy, Woosuk university, Wan-ju
55338, Korea Jeonjujongro Pharmacy, Jeonju, Korea
Introduction The number of degenerative arthritis patients continues to increase.
Medication should be combined with non-pharmaceutical treatment and
long-term and planned treatment.
Method The guidelines for the treatment of degenerative arthritis medication are
reviewed and compared with the cases of actual patients with chemotherapy.
Purpose In this study, we will examine the drug treatment guidelines for
degenerative arthritis and examine the latest trends in drug treatment for the
disease and identify appropriate guidance in administering medication guidance
for actual patients.
Result As a result of 20 cases analysis, pain management was mainly focused
and medication guidance was organized accordingly.
Conclusion In the case of degenerative arthrosis patients who visited the
pharmacy, it was most likely to long-term pain management through pain killers.
The drugs used for pain management were largely divided into three groups:
NSAIDs, Tramadol, and duloxetine, which were currently included in the drug
treatment guidelines for degenerative arthritis. Joins ® tended to be used as an
aid, but there were no reports of the previous three types of painkillers and
major drug interactions. In the case of medication guidance for degenerative
arthritis, it is designed to familiarize yourself with pain management through
painkillers and pain control groups, and it is necessary to collect clinical results
for auxiliary drugs such as Joins in the future.